Pharmaceutical firms reluctant to spend on R&D

A total of 30 pharmaceutical companies that chalked up the combined sales of over 3.8 trillion won for the first half of this year, invested 240.3 billion won in research, an average 6.3 percent of their revenue.

Yakup.com. says that 30 firms listed on the main bourse, excluding Hanmi Pharmaceutical and Korea United and Hanall Biopharma, have been reluctant to spend money on research and dev...